No CrossRef data available.
Article contents
Anticholinergic Anti-Parkinson Medication for Neuroleptic-induced Extrapyramidal Side Effects
Published online by Cambridge University Press: 29 January 2018
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Correspondence
- Information
- Copyright
- Copyright © 1986 The Royal College of Psychiatrists
References
Altamura, A. C.
et al. (1983) Italian Society of Biological Psychiatry. In Disipal in the Neuroleptic Syndrome, West Byfleet, Surrey: Brocades (Great Britain).Google Scholar
Bamrah, J. S., Kumar, V., Krska, J. & Soni, S. D. (1986) Interaction between procyclidine and neuroleptic drugs: some pharmacological and clinical aspects. British Journal of Psychiatry
(in press).CrossRefGoogle Scholar
Johnson, D. A. W. (1985) Antipsychotic medication: Clinical guidelines for maintenance therapy. Journal of Clinical Psychiatry, 5, 6–15.Google Scholar
Lader, M. (1980) Introduction to Psychopharmacology. A ‘Scope’ Publication. Kalamazoo, Michigan: Upjohn Company.Google Scholar
Shader, R. I.
Greenblatt, D. J. (1971) Uses and toxicity of bellandonna alkaloids and synthetic anticholinergics. Seminars in Psychiatry, 3, 449–76.Google Scholar
You have
Access
eLetters
No eLetters have been published for this article.